Rejected from Molecular Systems Biology? The 6 Best Journals to Submit Next

Source: Clarivate JCR 2024, EMBO Press, Cell Press, PLOS, Springer Nature, and Oxford University Press journal pages and guides for authors (accessed June 2026). eLife stopped reporting a JCR impact factor in the 2024 edition and is discussed separately below.

1. Cell Systems. This is the closest peer and the most natural landing spot for work that did not clear the EMBO Press systems bar but is genuinely systems biology. Cell Systems wants the systems layer to exist because it answers a biological question for a broad readership, which is the same test Molecular Systems Biology applies. It is less genomics-specific and less methods-led than Genome Biology, so it suits conceptual systems work over tool papers.

2. PLOS Computational Biology. The right home when the contribution is a computational method or model of exceptional significance across biological scales, and the experimental validation is partial rather than complete. It rewards methods that further understanding of living systems even when the wet-lab confirmation lives in a companion paper, which removes the untested-prediction risk that sinks computational manuscripts at MSB.

3. Genome Biology. If the work is genomics-, epigenomics-, or multi-omics-led, this venue frames that contribution well and explicitly covers systems and network biology. Reach for it when the data type, not the systems abstraction, is the protagonist, and when functional genomics or comparative genomics is the real story.

4. npj Systems Biology and Applications. The cleanest accessible step for technically sound systems work that the flagship judged too specialist. It is the Nature Portfolio open-access systems title, with a strong CiteScore (8.1) despite a lower IF, and it welcomes applications and synthetic-biology work that a higher-bar journal might consider niche. Submissions go through the Nature Portfolio system at Nature Portfolio journal page, so the file and metadata handoff is familiar if you have submitted to a Nature journal before.

5. Nature Communications. A good home when the contribution is broad and the systems angle is one strength among several. Its bar is high and its scope is multidisciplinary, so it suits work whose biological significance reaches beyond the systems-biology readership.

6. Bioinformatics (Oxford). Reach for this only when the core advance is a tool, algorithm, or software for bioinformatics and computational biology. It is the official journal of the International Society for Computational Biology and frames a method paper as a method paper, which is exactly the framing that fails at a systems-discovery journal.

Molecular Systems Biology is part of the EMBO Press cross-referral network and the Review Commons preprint-review platform that EMBO Press runs with ASAPbio. A rejecting editor can offer a one-click transfer that carries your manuscript files, and often the referee reports, to a more suitable journal in the family: EMBO Reports (shorter-format mechanistic work), EMBO Molecular Medicine (clinical-translation), or Life Science Alliance (open-access, lower bar).

Life Science Alliance explicitly considers manuscripts transferred with or without referee reports from Molecular Systems Biology. You can accept, decline, or ignore the offer and submit manually. A transfer offer is a routing suggestion, not a quality endorsement, so treat the destination as you would any other target.

One financial note before you decide: Molecular Systems Biology is fully gold open access with an APC of 6,890 USD, so a rejection here also resets that cost calculation. Some of the alternatives below carry a lower fee, which can matter when you weigh a transfer offer against a fresh submission elsewhere.

Practical ladder by rejection reason:

• Desk-rejected for scope or specialist interest (single-pathway mechanism, a tool with no biological claim, a dataset wearing a systems label)? Do not cascade inside the EMBO family unchanged; the scope problem follows the paper.

Pick the journal whose scope actually matches the work: Cell Systems for systems biology, Genome Biology for genomics, Bioinformatics for a tool, npj Systems Biology and Applications for an applications-flavored study.

• Rejected for insufficient conceptual advance but sound science? This is the classic transfer or step-across case. EMBO Reports, Life Science Alliance, or npj Systems Biology and Applications is the next tier.

Accept a cross-referral offer here if the suggested journal fits.

• Rejected after review because model predictions were never tested or the systems insight was thin? Fix it before resubmitting anywhere. Every serious systems venue will raise the same point. Carry the new validation experiment or integrative analysis into the transfer or the manual resubmission.

In our pre-submission review work with Molecular Systems Biology manuscripts, the rejections we see most often cluster into four named patterns. Each is journal-specific and testable against your own manuscript, which is what makes them worth checking before you resubmit anywhere.

The single-pathway study with no systems layer. Across our Molecular Systems Biology pre-submission reviews, the single most common desk-rejection trigger is a manuscript that characterizes one gene, protein, or pathway in mechanistic detail and never connects it to network or system-level behavior. The science can be excellent; the framing is molecular cell biology, not systems biology. Reviewers and editors ask whether the systems abstraction is load-bearing or decorative.

The fix is either a genuine integration step (network model, multi-condition dataset, emergent behavior) or an honest move to a mechanism-focused journal. This is testable: read your own abstract and ask whether the central claim is about a system or about a single component.

The method or dataset with no biological insight. A second recurring pattern is a clean computational tool, a new model, or a well-produced multi-omics dataset presented as the contribution, with no concrete biological question it resolves. The editorial question at this journal is not "is the method sound?" but "what does the system now reveal that we did not know?" Reviewers consistently flag the gap between a capable method and a missing discovery.

The fix is to lead with the biological claim the method enables, with the methods and the dataset in the supplementary material as support, or to send a pure tool to Bioinformatics instead.

Model predictions that are never tested. We see purely computational manuscripts whose central predictions are stated but never validated experimentally within the paper. Molecular Systems Biology expects a quantitative model or integrated framework that is tested, not just simulated. Reviewers reject when the figures show a model fit to existing data and a prediction that the authors never close the loop on.

Check that at least one non-trivial model prediction has an experiment, a held-out dataset, or an independent validation that confirms or refutes it. If you cannot run the experiment, PLOS Computational Biology is the more honest target.

Specialist interest framed as broad significance. The fourth pattern is a paper whose abstract claims wide biological significance that the results do not support, a study that is really about one organism, one condition, or one narrow question dressed as a general systems principle. The journal screens hard for broad significance, so the desk filter removes specialist work fast regardless of quality.

Read your abstract and ask: does the systems claim generalize, or is it one case study with an ambitious title? If it is a case study, reframe the contribution honestly and target a venue whose bar matches it.

Don't just resubmit the same file to the next journal. The fastest way to collect a second rejection is to send an unrevised manuscript to a venue that screens for the same thing Molecular Systems Biology did, and some manuscripts need real work, not a faster next submission. A desk rejection for scope or specialist interest is a routing problem you can fix by choosing the right journal and reframing the abstract to its bar.

A post-review rejection for untested predictions, a missing systems layer, or thin biological insight is a substance problem, and the same concerns will reappear at any serious venue. Be honest about which one you got.

Two cases call for real work before resubmitting, not a faster next submission. First, if reviewers said the model predictions were never tested, the manuscript needs at least one experimental or held-out validation that closes the loop. Second, if the systems framing was challenged as decorative, new integrative analysis (and sometimes new conditions or datasets) is the only fix.

Appealing is rarely worth it: a specialist-interest or conceptual-advance rejection is an editorial judgment, not a factual error, and the appeal queue is slower than a clean resubmission to a better-fit journal.